MiNK Therapeutics rockets 60% after collaboration with C-Further for pediatric cancers
Source: SeekingAlpha
2026-03-10 06:49:32 ET
Read the full article on Seeking Alpha
For further details see:
MiNK Therapeutics rockets 60% after collaboration with C-Further for pediatric cancers
MiNK Therapeutics Inc.
NASDAQ: INKT
INKT Trading
30.69% G/L:
$13.84 Last:
14,902,336 Volume:
$15.71 Open:
INKT Latest News
March 10, 2026 10:03:39 am
Strategic Partnerships and Platform Plays Power New Momentum Across Tech and Healthcare
March 10, 2026 05:30:00 am
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
INKT Stock Data
$94,552,132
3,709,418
0.69%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
